Marc Iskowitz

Here's why silver-haired Internet celebs might soon be making rounds on the Alzheimer's drug marketing scene.

There's a nettlesome gap between big-picture commercial strategy and front-line sales. Marketers say it's not likely to be bridged anytime soon.

Influencers are becoming a bigger part of pharmaceutical companies' marketing mix, and not just for helping firms gain a better understanding of their audiences.

This marks the fourth acquisition for Relevate, which plans to leverage games to round out its omnichannel life sciences offering.

It's more than just drugmakers' exorbitant prices. Experts say hospitals and patients both play a role.

Among biopharma firms, size didn't always correlate with the highest wages, a recently debuted analysis of ‘best' pharma workplaces shows.

The second annual MM+M/Publicis Health Pharma Marketing Transformation Survey shows innovation is beginning to take hold, although pharma still has a long way to go to digitally enable the marketing function.

The second annual survey shows pharma is making progress, but still has a long way to go to digitally enable the marketing function.

The dual challenges have spurred the industry to rethink its traditional comms and marketing priorities, a recent survey finds.

Set to become compulsory Nov. 20, the regulation isn't likely to make pharma ads easier for consumers to comprehend, but should aid in drugmakers' ability to meet the fair-balance standard.